210 related articles for article (PubMed ID: 17143261)
1. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.
Esposito NN; Chivukula M; Dabbs DJ
Mod Pathol; 2007 Jan; 20(1):130-8. PubMed ID: 17143261
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast.
Dabbs DJ; Kaplai M; Chivukula M; Kanbour A; Kanbour-Shakir A; Carter GJ
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):260-6. PubMed ID: 17721269
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.
Kuroda H; Tamaru J; Takeuchi I; Ohnisi K; Sakamoto G; Adachi A; Kaneko K; Itoyama S
Virchows Arch; 2006 Apr; 448(4):500-5. PubMed ID: 16538444
[TBL] [Abstract][Full Text] [Related]
4. Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies.
Yu J; Bhargava R; Dabbs DJ
Diagn Pathol; 2010 Jun; 5():36. PubMed ID: 20550696
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin and catenins in invasive mammary carcinomas.
Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
[TBL] [Abstract][Full Text] [Related]
6. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
7. [Expression of E-cadherin, p120catenin and 34βE12 in invasive lobular carcinoma of breast and their roles in diagnosis].
Yang GZ; Zhang XL; Li J; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):741-4. PubMed ID: 22336156
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions.
Sarrió D; Pérez-Mies B; Hardisson D; Moreno-Bueno G; Suárez A; Cano A; Martín-Pérez J; Gamallo C; Palacios J
Oncogene; 2004 Apr; 23(19):3272-83. PubMed ID: 15077190
[TBL] [Abstract][Full Text] [Related]
9. [Tubulolobular carcinoma of breast: a clinicopathologic study of 8 cases].
Shi J; Liang ZY; Meng ZL; Luo YF; Cao JL; Yang CM; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):681-5. PubMed ID: 23302310
[TBL] [Abstract][Full Text] [Related]
10. Invasive lobular carcinoma: to grade or not to grade.
Bane AL; Tjan S; Parkes RK; Andrulis I; O'Malley FP
Mod Pathol; 2005 May; 18(5):621-8. PubMed ID: 15605082
[TBL] [Abstract][Full Text] [Related]
11. Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival.
Nakopoulou L; Gakiopoulou-Givalou H; Karayiannakis AJ; Giannopoulou I; Keramopoulos A; Davaris P; Pignatelli M
Histopathology; 2002 Jun; 40(6):536-46. PubMed ID: 12047765
[TBL] [Abstract][Full Text] [Related]
12. Tubulolobular carcinoma of the breast: an analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile.
Wheeler DT; Tai LH; Bratthauer GL; Waldner DL; Tavassoli FA
Am J Surg Pathol; 2004 Dec; 28(12):1587-93. PubMed ID: 15577677
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
14. Usefulness and limitations of E-cadherin and β-catenin in the classification of breast carcinomas in situ with mixed pattern.
Gomes DS; Porto SS; Rocha RM; Gobbi H
Diagn Pathol; 2013 Jul; 8():114. PubMed ID: 23837653
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of E-cadherin and P120 catenin cocktail immunostain in distinguishing DCIS from LCIS.
Li X; Schwartz MR; Ro J; Hamilton CR; Ayala AG; Truong LD; Zhai QJ
Int J Clin Exp Pathol; 2014; 7(5):2551-7. PubMed ID: 24966968
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.
Rakha EA; Patel A; Powe DG; Benhasouna A; Green AR; Lambros MB; Reis-Filho JS; Ellis IO
Am J Surg Pathol; 2010 Oct; 34(10):1472-9. PubMed ID: 20871222
[TBL] [Abstract][Full Text] [Related]
17. P-cadherin expression in breast carcinoma indicates poor survival.
Peralta Soler A; Knudsen KA; Salazar H; Han AC; Keshgegian AA
Cancer; 1999 Oct; 86(7):1263-72. PubMed ID: 10506713
[TBL] [Abstract][Full Text] [Related]
18. Cytologic characteristics of tubulolobular carcinoma of the breast.
Boppana S; Erroll M; Reiches E; Hoda SA
Acta Cytol; 1996; 40(3):465-71. PubMed ID: 8669180
[TBL] [Abstract][Full Text] [Related]
19. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
